Quresh Khairullah, MD | |
18001 E 10 Mile Rd, Suite 1, Roseville, MI 48066-3803 | |
(586) 218-5800 | |
(586) 218-5808 |
Full Name | Quresh Khairullah |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 43 Years |
Location | 18001 E 10 Mile Rd, Roseville, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295737831 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | QK056739 (Michigan) | Primary |
207RN0300X | Internal Medicine - Nephrology | 49070 (Colorado) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Davita - Alpena Dialysis | Alpena, MI | Dialysis facility |
Grosse Pointe Dialysis Of Davita | Detroit, MI | Dialysis facility |
Midmichigan Medical Center - Alpena | Alpena, MI | Hospital |
Beaumont Hospital - Grosse Pointe | Grosse pointe, MI | Hospital |
Ascension St John Hospital | Detroit, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Clair Specialty Physicians Pc | 6204733256 | 36 |
News Archive
Oncolytics Biotech Inc. announced today that it has completed enrollment in the first, 80 patient stage of its Phase III clinical trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers (REO 018).
Researchers, led by scientists at the University of Colorado School of Medicine, have found basic molecular processes used by the Zika virus to "hijack" the cells that it infects and potentially how it makes molecules that are directly linked to disease.
A non-invasive imaging strategy which integrates non-invasive CT angiography (CTA) and CT myocardial perfusion imaging (CTP) has robust diagnostic accuracy for identifying patients with flow-limiting coronary artery disease in need of myocardial revascularisation, according to results of the CORE320 study presented here today by Dr Joao AC Lima from Johns Hopkins Hospital, Baltimore, USA.
FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.
BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial services, today announced it will be hosting a seminar on November 18, 2009 highlighting new research, trends and updates from industry experts in rheumatoid arthritis. This event, which will be held in Lafayette, PA, is part of the continuing series of symposia hosted by the company for pharmaceutical and medical imaging executives over the past four years that addresses the challenges and approaches in conducting clinical trials.
› Verified 4 days ago
Entity Name | St Clair Specialty Physicians Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154361616 PECOS PAC ID: 6204733256 Enrollment ID: O20040310000808 |
News Archive
Oncolytics Biotech Inc. announced today that it has completed enrollment in the first, 80 patient stage of its Phase III clinical trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers (REO 018).
Researchers, led by scientists at the University of Colorado School of Medicine, have found basic molecular processes used by the Zika virus to "hijack" the cells that it infects and potentially how it makes molecules that are directly linked to disease.
A non-invasive imaging strategy which integrates non-invasive CT angiography (CTA) and CT myocardial perfusion imaging (CTP) has robust diagnostic accuracy for identifying patients with flow-limiting coronary artery disease in need of myocardial revascularisation, according to results of the CORE320 study presented here today by Dr Joao AC Lima from Johns Hopkins Hospital, Baltimore, USA.
FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.
BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial services, today announced it will be hosting a seminar on November 18, 2009 highlighting new research, trends and updates from industry experts in rheumatoid arthritis. This event, which will be held in Lafayette, PA, is part of the continuing series of symposia hosted by the company for pharmaceutical and medical imaging executives over the past four years that addresses the challenges and approaches in conducting clinical trials.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Quresh Khairullah, MD 45640 Schoenherr Rd, Suite B, Shelby Township, MI 48315-6033 Ph: (586) 247-4300 | Quresh Khairullah, MD 18001 E 10 Mile Rd, Suite 1, Roseville, MI 48066-3803 Ph: (586) 218-5800 |
News Archive
Oncolytics Biotech Inc. announced today that it has completed enrollment in the first, 80 patient stage of its Phase III clinical trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers (REO 018).
Researchers, led by scientists at the University of Colorado School of Medicine, have found basic molecular processes used by the Zika virus to "hijack" the cells that it infects and potentially how it makes molecules that are directly linked to disease.
A non-invasive imaging strategy which integrates non-invasive CT angiography (CTA) and CT myocardial perfusion imaging (CTP) has robust diagnostic accuracy for identifying patients with flow-limiting coronary artery disease in need of myocardial revascularisation, according to results of the CORE320 study presented here today by Dr Joao AC Lima from Johns Hopkins Hospital, Baltimore, USA.
FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.
BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial services, today announced it will be hosting a seminar on November 18, 2009 highlighting new research, trends and updates from industry experts in rheumatoid arthritis. This event, which will be held in Lafayette, PA, is part of the continuing series of symposia hosted by the company for pharmaceutical and medical imaging executives over the past four years that addresses the challenges and approaches in conducting clinical trials.
› Verified 4 days ago
Robert Lewis Marchese, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 25810 Kelly Rd, Suite 3, Roseville, MI 48066 Phone: 586-777-9724 Fax: 586-777-9725 | |
Benjamin O Osowa, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18263 E 10 Mile Rd, Suite E, Roseville, MI 48066 Phone: 586-552-8696 Fax: 586-552-4404 | |
Dr. Majid Alzagoum, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18303 E 10 Mile Rd, Suite 100, Roseville, MI 48066 Phone: 586-776-8877 Fax: 586-776-3092 | |
Dr. Wahed Ishaqsei, M.D. Nephrology Medicare: May Accept Medicare Assignments Practice Location: 18263 E 10 Mile Rd, Suite D, Roseville, MI 48066 Phone: 586-778-4950 Fax: 586-778-4952 | |
Dr. Mohamad K. Ajjour, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18303 E 10 Mile Rd, Suite 100, Roseville, MI 48066 Phone: 586-776-8877 Fax: 586-776-3092 | |
Dr. Ameer Abdulrazzak, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18001 E 10 Mile, Suite 1, Roseville, MI 48066 Phone: 586-218-5800 Fax: 586-218-5808 | |
Dr. Madjid Mesgarzadeh, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 25910 Kelly Rd, Suite B, Roseville, MI 48066 Phone: 586-772-3366 Fax: 586-772-3355 |